(Q36688560)

English

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence

scientific article published on 13 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

1 reference

20 June 2019

1 reference

systematic review

1 reference

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence (English)

1 reference

Europe PubMed Central

15 August 2017

metabolic syndrome

1 reference

20 June 2019

prostate neoplasm

1 reference

20 June 2019

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Yu-zhu Xiang

1

1 reference

Europe PubMed Central

15 August 2017

Hui Xiong

2

1 reference

Europe PubMed Central

15 August 2017

Zi-lian Cui

3

1 reference

Europe PubMed Central

15 August 2017

Shao-bo Jiang

4

1 reference

Europe PubMed Central

15 August 2017

Qing-hua Xia

5

1 reference

Europe PubMed Central

15 August 2017

Yong Zhao

6

1 reference

Europe PubMed Central

15 August 2017

Guan-bin Li

7

1 reference

Europe PubMed Central

15 August 2017

Xun-bo Jin

8

1 reference

Europe PubMed Central

15 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 February 2013

4 references

Europe PubMed Central

15 August 2017

24 March 2019

3 April 2019

20 June 2019

Journal of Experimental & Clinical Cancer Research

2 references

Europe PubMed Central

15 August 2017

20 June 2019

32

1 reference

Europe PubMed Central

15 August 2017

9

1 reference

Europe PubMed Central

15 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

3 references

Europe PubMed Central

24 March 2019

Europe PubMed Central

3 April 2019

Europe PubMed Central

20 June 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1756-9966-32-9

0 references

Metabolic syndrome and risk of cancer: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Metabolic syndrome increases the risk of aggressive prostate cancer detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

The role of JAZF1 on lipid metabolism and related genes in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Racial differences in risk of prostate cancer associated with metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Metabolic syndrome and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Metabolic syndrome and risk of cancer mortality in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Obesity, metabolic syndrome, and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Symposium introduction: metabolic syndrome and the onset of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

30 September 2017

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

28 June 2018

Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Effect of metabolic syndrome on pathologic features of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

The metabolic syndrome and risk of prostate cancer in Italy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Metabolic syndrome and incidence of liver and breast cancers in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Metabolic syndrome is associated with colorectal cancer in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Metabolic syndrome and cancer risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

The metabolic syndrome is associated with reduced risk of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3598969

5 September 2018

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-9

21 January 2018

Metabolic syndrome and endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-9

21 January 2018

Features of the metabolic syndrome and prostate cancer in African-American men

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-9

21 January 2018

Prospective study on metabolic factors and risk of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome in adult cancer survivors: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of metabolic syndrome on biochemical recurrence of prostate cancer after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23406686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-9966-32-9

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

release_zc2oryquzjcs3cd7ra6xjl5ehm

1 reference

https://api.fatcat.wiki/v0/release/zc2oryquzjcs3cd7ra6xjl5ehm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36688560&oldid=1844704472"